Showing results (1741-1750 of 9,980) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|February 28, 2020
Response to hyperfractionated accelerated radiotherapy in chemotherapy-refractory non-Hodgkin lymphomaDaniel W Kim, Grace Lee, Hwan Lee, et al.
Leukemia & Lymphoma|March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.
Leukemia & Lymphoma|March 12, 2020
Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective studyKensuke Takaoka, Junji Koya, Akihide Yoshimi, et al.
Leukemia & Lymphoma|July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysisAbdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Leukemia & Lymphoma|July 15, 2021
Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphomaGrace T Baek, Noah J Mathis, Anthony J Perissinotti, et al.
Leukemia & Lymphoma|December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomasNina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Leukemia & Lymphoma|July 5, 2022
Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribineFelix Klingler, Winfried H Alsdorf, Susanne Ghandili, et al.
Leukemia & Lymphoma|November 21, 2022
Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database studyPeter Feng Wang, Christopher W Yee, Boris Gorsh, et al.
Leukemia & Lymphoma|July 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial designKristine Broglio, Lale Kostakoglu, Carol Ward, et al.
Leukemia & Lymphoma|January 18, 2014
High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab eraYngvild N Blaker, Marianne B Eide, Knut Liestøl, et al.
Pageof 998